Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma.
Sajisevi M, Nguyen K, Callas P, Holcomb AJ, Vural E, Davis KP, Thomas CM, Plonowska-Hirschfeld KA, Stein JS, Eskander A, Kakarala K, Enepekides DJ, Hier MP, Ryan WR; American Head and Neck Society Salivary Gland Section; Asarkar AA, Aulet R, Bell RK, Blasco MA, Bowmaster VB, Burruss CP, Chung J, Chan K, Chang BA, Coffey CS, Cognetti DM, Cooper DJ, Cordero J, Donovan J, Du YJ, Dundar Y, Dedivitis RA, Edwards HA, Erovic BM, Feinberg PA, Garvey EA, Goldstein DP, Goodman JF, Goulart RN, Goyal N, Grasl S, Giurintano JP, Gupta N, Habib AM, Hackman TG, Hara JH, Henson C, Hinni ML, Hua N, Johnson-Obaseki S, Juloori A, Kalman NS, Kejner AE, Khaja SF, Ku JA, Lambert A, Luu BK, Magliocca KR, Dos Santos LRM, Michael C, Miles BA, de Melo GM, Moore MG, Morand GB, Moura K, Mukdad L, Noroozi H, Patel R, Paydarfar JA, Sadeghi N, Savaria FN, Schmitt NC, Shapiro J, Shaver TB, Stoeckli SJ, St John M, Stokes WA, Sulibhavi A, Tasoulas J, Vendra V, Vinh DB, Virgen CG, Wooten C, Woody NM, Young GD.
Sajisevi M, et al. Among authors: ryan wr.
JAMA Otolaryngol Head Neck Surg. 2024 Feb 1;150(2):107-116. doi: 10.1001/jamaoto.2023.3952.
JAMA Otolaryngol Head Neck Surg. 2024.
PMID: 38095911
